Return to search

Marketing costs incurred within the ethical pharmaceutical industry

Recent governmental enquiries into the Canadian Pharmaceutical industry have recommended that the level of marketing costs incurred by individual firms be reduced, so that the cost of medication may in turn be reduced. The object of this study is to seek out and apply quantitative techniques that objectively measure the effectiveness of various pharmaceutical firms' marketing departments.
This is subsequently related to the firms' marketing policies and the costs of their implementation.
The effectiveness of six pharmaceutical firms' marketing departments was determined by two methods: (1) a ratio measure of each firm's rate of return to the level of its marketing costs; and (2) a productivity measure that permits
the calculation of relative efficiencies. It was determined that the general quantitative results were consistent for either method of calculation. In addition, not only was there a wide degree of variance between the individual
firm's marketing effectiveness, but it appears that firms who adopted an indirect distribution policy and a mass selling promotional policy had a more efficient marketing department. / Business, Sauder School of / Graduate

Identiferoai:union.ndltd.org:UBC/oai:circle.library.ubc.ca:2429/35799
Date January 1968
CreatorsFevang, Leroy Conrad
PublisherUniversity of British Columbia
Source SetsUniversity of British Columbia
LanguageEnglish
Detected LanguageEnglish
TypeText, Thesis/Dissertation
RightsFor non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.

Page generated in 0.0026 seconds